Samsung Biologics reassures clients as South Korean coronavirus cases grow

21 Feb 2020

South Korea’s Samsung Biologics has sought to reassure clients that it is business as usual at the contract development and manufacturing organisation (CDMO) as the number of confirmed coronavirus (COVID-19) infections in the country continues to soar.

In a statement Friday, the company said it had deployed a formal business continuity plan to manage the COVID-19 situation.

Samsung Biologics reassures clients as South Korean coronavirus cases grow

It is now monitoring employees’ and visitors’ health and recent travel history and has installed infrared thermal cameras at all entrances and added steps during visitor registration to screen for symptoms of the virus.

“Employees with any symptoms and anyone within direct contact are under self-quarantine. A dedicated task force is also in place to actively monitor and manage the situation around the clock should there be any case in the future,” the company said.

Samsung said it is also conducting daily assessments of any potential impact on the supply chain, deep-cleaning and disinfecting of plant and business facilities and promoting hygiene awareness and individual precautionary measures.

Samsung said that as of 21 February, none of its employees have been diagnosed with COVID-19, with only one confirmed case to date in Incheon, where the CDMO is headquartered.

“Samsung Biologics will continue to take preventative and responsive measures to protect our employees from the spread of COVID-19 at all times,” the company said. “While fully supporting our employees during this global crisis, we are also rigorously implementing all measures to ensure that there is no disruption to the safe delivery of client products and services.”

Since its launch in 2011, Samsung has been expanding its service offerings beyond manufacturing with development and laboratory testing services. It recently announced it will open a research and development centre for its contract development organization (CDO) business in San Francisco later this year.